Myocardial Bridging
1The First Hospital of Putian, Teaching Hospital, Fujian Medical University, Fujian Province, China.
Insights
Myocardial bridging, a rare condition affecting coronary arteries, can lead to serious cardiac events. Surgical myotomy is preferred for symptomatic patients unresponsive to medical treatment.
Area of Science:
- Cardiology
- Vascular Surgery
Background:
- Myocardial bridging is an uncommon congenital anomaly where a segment of a coronary artery travels through the heart muscle.
- It is most frequently observed in the mid-left anterior descending coronary artery, with diverse anatomical variations.
- Endothelial changes and vasoactive substances can influence atherosclerosis progression in myocardial bridging.
Purpose of the Study:
- To review the clinical presentation, pathophysiology, and management of myocardial bridging.
- To highlight the efficacy of surgical myotomy versus other interventions.
Main Methods:
- Literature review of myocardial bridging cases.
- Analysis of clinical presentations, diagnostic findings, and treatment outcomes.
Main Results:
- Symptoms include chest pain, myocardial infarction, arrhythmia, and sudden death.
- Medical management with beta-blockers is often insufficient for severe cases.
- Surgical myotomy is the preferred intervention for symptomatic patients.
- Coronary stent deployment shows limited long-term efficacy.
Conclusions:
- Myocardial bridging requires careful management, especially in symptomatic individuals.
- Surgical myotomy offers a viable solution for patients with poor response to medical therapy.
- Further research is needed to improve long-term outcomes for myocardial bridging interventions.
Abstract:
Myocardial bridging is rare. Myocardial bridges are most commonly localized in the middle segment of the left anterior descending coronary artery. The anatomic features of the bridges vary significantly. Alterations of the endothelial morphology and the vasoactive agents impact on the progression of atherosclerosis of myocardial bridging. Patients may present with chest pain, myocardial infarction, arrhythmia and even sudden death. Patients who respond poorly to the medical treatment with β-blockers warrant a surgical intervention. Myotomy is a preferred surgical procedure for the symptomatic patients. Coronary stent deployment has been in limited use due to the unsatisfactory long-term results.
Related Concept Videos
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Structure of Cardiac Muscles
Compared to skeletal muscles, cardiac muscle cells are small and mostly have a single nucleus. Additionally, they are usually...
Cardiomyopathy I: Introduction and Classification
Myocarditis I: Introduction


